DIFFERENTIAL SPLICING OF COL4A5 MESSENGER-RNA IN KIDNEY AND WHITE BLOOD-CELLS - A COMPLEX MUTATION IN THE COL4A5 GENE OF AN ALPORT PATIENT DELETES THE NC1 DOMAIN

被引:26
作者
GUO, CY
VANDAMME, B
VANDAMMELOMBAERTS, R
VANDENBERGHE, H
CASSIMAN, JJ
MARYNEN, P
机构
[1] CATHOLIC UNIV LEUVEN, CTR HUMAN GENET,CAMPUS GASTHUISBERG,O&N6,HERSTR 49, B-3000 LOUVAIN, BELGIUM
[2] UNIV HOSP LEUVEN, DEPT PATHOL, LOUVAIN, BELGIUM
[3] UNIV HOSP LEUVEN, DEPT PEDIAT, LOUVAIN, BELGIUM
关键词
D O I
10.1038/ki.1993.384
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PCR conditions were optimized to amplify the COL4A5 cDNA from lymphoblasts and kidney tissue. Sequencing of the COL4A5 mRNA isolated from the kidney of an Alport syndrome patient revealed two differences with the published sequence. One divergence, the insertion of an 18 bp sequence between exon 11 and 10 of the COL4A5 mRNA added two Gly-X-Y triplets to the COL4A5 sequence and was subsequently found in the mRNA of four normal kidney mRNA samples. This sequence was absent in all white blood cell RNA samples sequenced by us, indicating tissue specific splicing with the presence of an additional exon in kidney COL4A5 mRNA. This finding of differential splicing of COL4A5 mRNA in kidney and white blood cells might affect the use of white blood cell mRNA for the analysis of Alport mutations. Second, a complex mutation was detected in the mRNA from the AS patient introducing a premature stop codon in the message, deleting part of the triple helical domain and the complete NC domain. The mother of the patient was shown to be heterozygous for this mutation.
引用
收藏
页码:1316 / 1321
页数:6
相关论文
共 24 条
[1]   ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS - DELETIONS IN THE 5' END OF THE COL4A5 COLLAGEN GENE [J].
ANTIGNAC, C ;
ZHOU, J ;
SANAK, M ;
COCHAT, P ;
ROUSSEL, B ;
DESCHENES, G ;
GROS, F ;
KNEBELMANN, B ;
HORSCAYLA, MC ;
TRYGGVASON, K ;
GUBLER, MC .
KIDNEY INTERNATIONAL, 1992, 42 (05) :1178-1183
[2]  
ATKIN CL, 1988, AM J HUM GENET, V42, P249
[3]   MAJOR REARRANGEMENTS IN THE ALPHA-5(IV) COLLAGEN GENE IN 3 PATIENTS WITH ALPORT SYNDROME [J].
BOYE, E ;
VETRIE, D ;
FLINTER, F ;
BUCKLE, B ;
PIHLAJANIEMI, T ;
HAMALAINEN, ER ;
MYERS, JC ;
BOBROW, M ;
HARRIS, A .
GENOMICS, 1991, 11 (04) :1125-1132
[4]  
BRUNNER H, 1988, KIDNEY INT, V34, P506
[5]   ILLEGITIMATE (OR ECTOPIC) TRANSCRIPTION PROCEEDS THROUGH THE USUAL PROMOTERS [J].
CHELLY, J ;
HUGNOT, JP ;
CONCORDET, JP ;
KAPLAN, JC ;
KAHN, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 178 (02) :553-557
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[7]   GENETICS OF CLASSIC ALPORTS-SYNDROME [J].
FLINTER, FA ;
CHANTLER, C ;
CAMERON, JS ;
HOUSTON, I ;
BOBROW, M .
LANCET, 1988, 2 (8618) :1005-1007
[8]   IDENTIFICATION OF A DISTINCT TYPE-IV COLLAGEN ALPHA-CHAIN WITH RESTRICTED KIDNEY DISTRIBUTION AND ASSIGNMENT OF ITS GENE TO THE LOCUS OF X-CHROMOSOME-LINKED ALPORT SYNDROME [J].
HOSTIKKA, SL ;
EDDY, RL ;
BYERS, MG ;
HOYHTYA, M ;
SHOWS, TB ;
TRYGGVASON, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1606-1610
[9]  
KNEBELMANN B, 1992, AM J HUM GENET, V51, P135
[10]  
MRAD R, 1992, HUM GENET, V90, P420